FHH: adverse reactions of plant drugs should be monitored intensively

The 8th executive session of the Western Pacific herbal coordination Forum (FHH) ended in Hong Kong Officials and scholars from drug administration authorities and research institutions in Australia, China, Hong Kong SAR, Japan, South Korea, Singapore and Vietnam attended the meeting At the meeting, the relevant officials of the drug registration department of the State Food and Drug Administration introduced the latest situation of the construction of the adverse reactions monitoring system of traditional Chinese medicine in China, pointed out that the adverse reactions of botanical drugs should be intensively monitored and studied, and a set of practical monitoring methods for botanical drugs should be established Narantuya samdan, consultant of traditional medicine in the Western Pacific Regional Office of the World Health Organization, pointed out that there is a wide market for botanical drugs in the Western Pacific region However, there is a general lack of systematic clinical research to prove its safety and effectiveness, so it is necessary to increase evidence-based medicine research on traditional drugs It is reported that FHH is a technical forum, whose main responsibility is to reach an agreement on specific issues around the quality, effectiveness and safety of herbal medicines, and form normative documents to provide reference for drug administration and regulatory agencies in various countries It is mainly composed of drug administration and supervision departments and funding teams Its member countries include 6 countries and 1 region, namely Australia, China, Hong Kong SAR of China, Japan, South Korea, Singapore and Vietnam.